Target intelligence / Profile preview

Norrin cystine knot growth factor (NDP)

Target
NDP
Molecular classification
Growth factor, Cystine knot growth factor superfamily, Atypical Wnt ligand, Secreted protein
01

Overview

Norrin cystine knot growth factor (NDP) is a secreted, cysteine-rich protein that forms a unique homodimer with each subunit adopting a cystine knot fold[1][2][3]. Norrin functions as an atypical Wnt ligand, activating Wnt/β-catenin signaling specifically through binding Frizzled-4 receptor and Lrp5/6 co-receptors, which is crucial for vascular development in the retina, cochlea, and central nervous system[1][2][3][4]. Mutations in the NDP gene cause Norrie disease and related disorders characterized by retinal vascularization defects, progressive vision loss, and sometimes hearing impairment or intellectual disability[4]. Norrin's role is essential in retinal angiogenesis and the maintenance of blood–retinal barrier integrity. There are no marketed drugs directly targeting Norrin, but its signaling pathway is of significant research interest for inherited vascular diseases of the eye.

Other names
NorrinNDPEVR2Norrie disease proteinX-linked exudative vitreoretinopathy 2 proteinFEVRND
02

Mechanism of action

Ligand for Frizzled-4 receptor: Binds to Frizzled-4 (Fz4) and co-receptors Lrp5/6, activating the canonical Wnt/β-catenin signaling pathway, promoting vascular development[1][2][3]

03

Biological functions

Angiogenesis (formation of new blood vessels)Activation of Wnt/β-catenin signaling pathwayRegulation of vascular development in the eye, ear, brain, and female reproductive organs
04

Disease associations

Hereditary eye diseases (Norrie disease [pseudoglioma])X-linked exudative vitreoretinopathyAbnormal vascular developmentFamilial exudative vitreoretinopathy (FEVR)
05

Safety considerations

Therapeutic modulation is not established; deficiencies or mutations result in congenital blindness, hearing loss, and sometimes intellectual disability.No drug-related safety concerns are documented because it is not directly targeted by any approved therapy.
06

Biomarkers

Presence of NDP gene mutations is a genetic biomarker for diseases such as Norrie disease and familial exudative vitreoretinopathy (FEVR)[4]

Beyond the preview

Go deeper on Norrin cystine knot growth factor (NDP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norrin cystine knot growth factor (NDP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call